Team:EPF-Lausanne/Our Project/Assembly

From 2011.igem.org

(Difference between revisions)
(TetR plasmid)
Line 98: Line 98:
We amplified this backbone, and added '''TetR''' under '''constitutive promoter''' to it.
We amplified this backbone, and added '''TetR''' under '''constitutive promoter''' to it.
 +
{|  
{|  
Line 113: Line 114:
|}
|}
 +
Details of the parts assembled:
 +
* Plasmid backbone: pSB3K1 from ETHZ 2007 [http://partsregistry.org/wiki/index.php?title=Part:pSB3K1 "pSB3K1"] (taken from the delivery plate)
 +
* Pconst: J23116 from Berkeley 2006 [http://partsregistry.org/Part:BBa_J23116 "j23116"] (sequence copied into our primers)
 +
* RBS (B0034?) and spacer: (sequence copied into our primers)
 +
* TetR: [https://static.igem.org/mediawiki/2011/b/b0/EPFL_TetR_sequence.txt "TetR sequence"] (623 bp) The sequence lacks a stop codon, we added TAA with our primers
[[File:EPFL_Tetr_plasmid.jpg|300px]]
[[File:EPFL_Tetr_plasmid.jpg|300px]]
Line 118: Line 124:
Our TetR plasmid contains a p15A replication origin, the same medium-copy number as in J61002 to ensure that during cotransformations the 2 different plasmids are present in same amounts. The plasmids carries a Kanamycin resistance marker, also because of cotransformations with J61002: we need a different selection antibiotic for each plasmid. We chose a constitutive promoter that was intermediarily strong, in order to have more repression of the lysis cassette by LacI in the Lysis-Inverter cotransformation, giving a better chance of surviving to the cells.
Our TetR plasmid contains a p15A replication origin, the same medium-copy number as in J61002 to ensure that during cotransformations the 2 different plasmids are present in same amounts. The plasmids carries a Kanamycin resistance marker, also because of cotransformations with J61002: we need a different selection antibiotic for each plasmid. We chose a constitutive promoter that was intermediarily strong, in order to have more repression of the lysis cassette by LacI in the Lysis-Inverter cotransformation, giving a better chance of surviving to the cells.
 +
=== Cutting out RFP ===
=== Cutting out RFP ===
Line 127: Line 134:
Now we have the expected TetR plasmid and we can go on with our assembly strategy.
Now we have the expected TetR plasmid and we can go on with our assembly strategy.
 +
 +
Complete sequence of the plasmid: [https://static.igem.org/mediawiki/2011/5/5a/EPFL_PSB3K1_Pconst-TetR.txt "pSb3K1 Pconst-TetR"]
 +
This plasmid was successfully sequence-verified:
 +
*Sequencing data compared to the sequence of Pconst,RBS+spacer and TetR gene:[https://static.igem.org/mediawiki/2011/2/23/EPFL_pSb3K1_TetR_seq.txt "pSb3K1_TetR_seq"]
 +
=== Adding Ptet-LacI (Inverter plasmid) ===
=== Adding Ptet-LacI (Inverter plasmid) ===

Revision as of 15:16, 14 September 2011